JP2017509713A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509713A5 JP2017509713A5 JP2017502571A JP2017502571A JP2017509713A5 JP 2017509713 A5 JP2017509713 A5 JP 2017509713A5 JP 2017502571 A JP2017502571 A JP 2017502571A JP 2017502571 A JP2017502571 A JP 2017502571A JP 2017509713 A5 JP2017509713 A5 JP 2017509713A5
- Authority
- JP
- Japan
- Prior art keywords
- aluminum
- adsorbed
- immunogen
- aluminum salt
- mpla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461969905P | 2014-03-25 | 2014-03-25 | |
| US61/969,905 | 2014-03-25 | ||
| PCT/US2014/045940 WO2015147899A1 (en) | 2014-03-25 | 2014-07-09 | Methods for enhancing the immunostimulation potency of aluminum salt-adsorbed vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017509713A JP2017509713A (ja) | 2017-04-06 |
| JP2017509713A5 true JP2017509713A5 (enExample) | 2017-08-17 |
Family
ID=51302762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502571A Pending JP2017509713A (ja) | 2014-03-25 | 2014-07-09 | アルミニウム塩に吸着させたワクチンの免疫賦活能を強化するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20170165358A1 (enExample) |
| EP (1) | EP3122379A1 (enExample) |
| JP (1) | JP2017509713A (enExample) |
| KR (1) | KR20170016315A (enExample) |
| CN (1) | CN106535929A (enExample) |
| AU (1) | AU2014388299A1 (enExample) |
| BR (1) | BR112016021692A2 (enExample) |
| CA (1) | CA2943050A1 (enExample) |
| MX (1) | MX2016012166A (enExample) |
| RU (1) | RU2016141621A (enExample) |
| SG (2) | SG10201808312YA (enExample) |
| WO (1) | WO2015147899A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2997211A1 (en) | 2015-08-19 | 2017-02-23 | President And Fellows Of Harvard College | Lipidated psa compositions and methods |
| CA3030974A1 (en) | 2016-07-15 | 2018-01-18 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
| JP7385206B2 (ja) * | 2018-12-04 | 2023-11-22 | 国立大学法人大阪大学 | 免疫賦活剤 |
| US20230134067A1 (en) * | 2020-07-22 | 2023-05-04 | 3H Bio. Co., Ltd. | A peptide used for immunotherapeutics |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1124013A (zh) * | 1993-02-19 | 1996-06-05 | 史密丝克莱恩比彻姆公司 | 含3-邻位-脱酰基的单磷酰基脂质a的流感疫苗组合物 |
| WO1994019013A1 (en) * | 1993-02-19 | 1994-09-01 | Smithkline Beecham Corporation | Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a |
| ES2162139T5 (es) * | 1993-03-23 | 2008-05-16 | Smithkline Beecham Biologicals S.A. | Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado. |
| EP1850871A2 (en) * | 2005-02-16 | 2007-11-07 | Novartis Vaccines and Diagnostics, Inc. | Adjuvant composition comprising aluminium phosphate and 3d-mpl |
| US20090035360A1 (en) * | 2007-05-24 | 2009-02-05 | Dominique Ingrid Lemoine | Lyophilised antigen composition |
| SG184188A1 (en) * | 2010-03-26 | 2012-10-30 | Glaxosmithkline Biolog Sa | Hiv vaccine |
-
2014
- 2014-07-09 BR BR112016021692A patent/BR112016021692A2/pt not_active Application Discontinuation
- 2014-07-09 JP JP2017502571A patent/JP2017509713A/ja active Pending
- 2014-07-09 CA CA2943050A patent/CA2943050A1/en not_active Abandoned
- 2014-07-09 RU RU2016141621A patent/RU2016141621A/ru not_active Application Discontinuation
- 2014-07-09 KR KR1020167025974A patent/KR20170016315A/ko not_active Withdrawn
- 2014-07-09 SG SG10201808312YA patent/SG10201808312YA/en unknown
- 2014-07-09 US US15/127,076 patent/US20170165358A1/en not_active Abandoned
- 2014-07-09 WO PCT/US2014/045940 patent/WO2015147899A1/en not_active Ceased
- 2014-07-09 EP EP14750386.6A patent/EP3122379A1/en not_active Withdrawn
- 2014-07-09 MX MX2016012166A patent/MX2016012166A/es unknown
- 2014-07-09 AU AU2014388299A patent/AU2014388299A1/en not_active Abandoned
- 2014-07-09 CN CN201480077507.5A patent/CN106535929A/zh active Pending
- 2014-07-09 SG SG11201607404PA patent/SG11201607404PA/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shah et al. | Overview of vaccine adjuvants: introduction, history, and current status | |
| Yang et al. | Recent advances in the development of toll-like receptor agonist-based vaccine adjuvants for infectious diseases | |
| Leroux-Roels | Unmet needs in modern vaccinology: adjuvants to improve the immune response | |
| JP2018521028A5 (enExample) | ||
| Atmar et al. | Adjuvants for pandemic influenza vaccines | |
| Kocourkova et al. | Vaccine ingredients: components that influence vaccine efficacy | |
| JP2011504486A5 (enExample) | ||
| JP2014506916A5 (enExample) | ||
| JP2009539965A5 (enExample) | ||
| JP2011500662A5 (enExample) | ||
| JP2008534467A5 (enExample) | ||
| JP2017509713A5 (enExample) | ||
| JP2015509522A5 (enExample) | ||
| Stegmann et al. | Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation | |
| JP5712126B2 (ja) | 遅延型追加刺激免疫処置に対する迅速な応答 | |
| JP2015531389A5 (enExample) | ||
| JP6564367B2 (ja) | 併用免疫原性組成物 | |
| JP2003526676A (ja) | ワクチン用のアジュバント | |
| NZ514961A (en) | Combination vaccines for protection against Streptococcus pneumoniae and RSV infection in children and the elderly | |
| JP2018172417A (ja) | 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法 | |
| RU2017129340A (ru) | Композиции nеisseria мeningitidis и способы их получения | |
| JP2011506334A5 (enExample) | ||
| WO2017122635A1 (ja) | 固定化ウイルス粒子を含むワクチン | |
| RU2016141621A (ru) | Способы усиления эффективности иммуностимуляции адсорбированных на соли алюминия вакцин | |
| JP2015509963A5 (enExample) |